Search Results
Matches for acronym IR
453
rows returned
Results are ranked by score and user rating. Use the quick vote buttons when a candidate clearly matches or clearly does not.
| Acronym | Full Name | Score | User Rating | Judge | Search |
|---|---|---|---|---|---|
| IR | immunoreactive | 205 | 5 |
|
|
| IR | immunoreactivity | 149 | 10 |
|
|
| IR | insulin receptor | 134 | 5 |
|
|
| IR | ionizing radiation | 90 | 13 |
|
|
| IR | Insulin Resistance | 62 | 9 |
|
|
| IR | infrared | 61 | 8 |
|
|
| IR | inverted repeat | 32 | 20 |
|
|
| IR | immune response | 32 | 12 |
|
|
| IR | immune response | 32 | 12 |
|
|
| IR | Immediate Release | 23 | 3 |
|
|
| IR | inversion recovery | 22 | 8 |
|
|
| IR | infrared spectroscopy | 17 | 14 |
|
|
| IR | incidence rate | 16 | 10 |
|
|
| IR | ischemia-reperfusion | 15 | 13 |
|
|
| IR | inhibition rate | 13 | 21 |
|
|
| IR | immediate-release | 12 | 16 |
|
|
| IR | (NPY)-immunoreactive | 8 | 12 |
|
|
| IR | ionising radiation | 7 | 4 |
|
|
| IR | insulin receptors | 6 | 12 |
|
|
| IR | GABA-immunoreactive | 6 | 10 |
|
|
| IR | CGRP-immunoreactive | 6 | 10 |
|
|
| IR | (TH)-immunoreactive | 6 | 9 |
|
|
| IR | (CGRP)-immunoreactive | 6 | 7 |
|
|
| IR | incomplete repair | 6 | 5 |
|
|
| IR | ischemia and reperfusion | 6 | 3 |
|
|
| IR | SP-immunoreactive | 5 | 15 |
|
|
| IR | immunoreactivities | 5 | 14 |
|
|
| IR | HOMA | 5 | 1 |
|
|
| IR | ChAT-immunoreactive | 4 | 15 |
|
|
| IR | inferior rectus | 4 | 15 |
|
|
| IR | near-infrared | 4 | 15 |
|
|
| IR | Fos-immunoreactive | 4 | 12 |
|
|
| IR | NPY-immunoreactive | 4 | 12 |
|
|
| IR | interventional radiology | 4 | 12 |
|
|
| IR | (5-HT)-immunoreactive | 4 | 11 |
|
|
| IR | information retrieval | 4 | 11 |
|
|
| IR | interquartile range | 4 | 10 |
|
|
| IR | inverted repeats | 4 | 5 |
|
|
| IR | (SP)-immunoreactive | 4 | 3 |
|
|
| IR | Inversion-Recovery | 4 | 2 |
|
|
| IR | serotonin-immunoreactive | 3 | 16 |
|
|
| IR | inwardly rectifying | 3 | 16 |
|
|
| IR | instant release | 3 | 15 |
|
|
| IR | ubiquitin-immunoreactive | 3 | 15 |
|
|
| IR | inactive renin | 3 | 13 |
|
|
| IR | intestinal polypeptide (VIP)-immunoreactive | 3 | 12 |
|
|
| IR | intergenic region | 3 | 11 |
|
|
| IR | (NOS)-immunoreactive | 3 | 11 |
|
|
| IR | incidence rates | 3 | 11 |
|
|
| IR | interdigitating reticulum | 3 | 11 |
|
|
| IR | infra-red | 3 | 10 |
|
|
| IR | 5-immunoreactive | 3 | 10 |
|
|
| IR | ileal reservoir | 3 | 9 |
|
|
| IR | implantation rate | 3 | 8 |
|
|
| IR | VT-immunoreactive | 2 | 18 |
|
|
| IR | input resistance | 2 | 18 |
|
|
| IR | NOS-immunoreactivity | 2 | 17 |
|
|
| IR | VIP-immunoreactive | 2 | 15 |
|
|
| IR | intraruminal | 2 | 15 |
|
|
| IR | LHRH-immunoreactive | 2 | 15 |
|
|
| IR | NOS-immunoreactive | 2 | 14 |
|
|
| IR | increased the number of Fos-immunoreactive | 2 | 13 |
|
|
| IR | in levels of immunoreactive | 2 | 13 |
|
|
| IR | insulin release | 2 | 12 |
|
|
| IR | Irradiation | 2 | 12 |
|
|
| IR | SUR1/K | 2 | 12 |
|
|
| IR | Induction of Fos-like immunoreactivity | 2 | 12 |
|
|
| IR | imidazoline receptors | 2 | 12 |
|
|
| IR | PKC-beta-immunoreactive | 2 | 12 |
|
|
| IR | IGF-I receptors (IGF-IR) and insulin receptors | 2 | 11 |
|
|
| IR | CaBP-immunoreactive | 2 | 11 |
|
|
| IR | innervation ratio | 2 | 11 |
|
|
| IR | inhibitory ratio | 2 | 11 |
|
|
| IR | c-Fos-immunoreactive | 2 | 11 |
|
|
| IR | inward rectifier K(+) (K | 2 | 10 |
|
|
| IR | inducible resistance | 2 | 10 |
|
|
| IR | GFAP-immunoreactivity | 2 | 9 |
|
|
| IR | (CRH)-immunoreactive | 2 | 9 |
|
|
| IR | GnRH-immunoreactive | 2 | 9 |
|
|
| IR | (AVP)-immunoreactive | 2 | 9 |
|
|
| IR | intestinal peptide (VIP)-immunoreactive | 2 | 9 |
|
|
| IR | infrared spectrophotometry | 2 | 9 |
|
|
| IR | T-immunoreactivity | 2 | 8 |
|
|
| IR | Infrared spectra | 2 | 8 |
|
|
| IR | in ischemia-reperfusion | 2 | 8 |
|
|
| IR | internal rotation | 2 | 7 |
|
|
| IR | in immunoreactive | 2 | 7 |
|
|
| IR | (CRF)-immunoreactive | 2 | 6 |
|
|
| IR | infection rates | 2 | 6 |
|
|
| IR | AM-immunoreactive | 2 | 5 |
|
|
| IR | PACAP-immunoreactive | 2 | 4 |
|
|
| IR | PNMT-immunoreactive | 2 | 3 |
|
|
| IR | ischaemia-reperfusion | 2 | 1 |
|
|
| IR | peptide-immunoreactive | 2 | -2 |
|
|
| IR | (TH)-only'-immunoreactive | 1 | 22 |
|
|
| IR | alpha-immunoreactivity | 1 | 21 |
|
|
| IR | in groups II | 1 | 20 |
|
|
| IR | immuno-reactivities | 1 | 20 |
|
|
| IR | increase ratio | 1 | 20 |
|
|
| IR | Immunohistochemical analyses revealed that c-Met-immunoreactivity | 1 | 19 |
|
|
| IR | increase in plasma immunoreactive | 1 | 19 |
|
|
| IR | VMAT2-immunoreactivity | 1 | 19 |
|
|
| IR | IFABP-immunoreactive | 1 | 19 |
|
|
| IR | in the HOMA-insulin resistant | 1 | 19 |
|
|
| IR | incident review | 1 | 19 |
|
|
| IR | implant withdrawal | 1 | 19 |
|
|
| IR | inactive renin levels | 1 | 18 |
|
|
| IR | intracellular distribution of immunoreactive | 1 | 18 |
|
|
| IR | increase in intracellular NO in NIH-3T3 | 1 | 18 |
|
|
| IR | infectious rhinitis | 1 | 18 |
|
|
| IR | incomplete resection alone | 1 | 18 |
|
|
| IR | infrared marker | 1 | 18 |
|
|
| IR | imidazol(in)e | 1 | 18 |
|
|
| IR | FGF-immunoreactivity | 1 | 18 |
|
|
| IR | VRL-1-immunoreactive | 1 | 17 |
|
|
| IR | inversion-time (TI) inversion-recovery | 1 | 17 |
|
|
| IR | Initial drug resistance | 1 | 17 |
|
|
| IR | in the infrared | 1 | 17 |
|
|
| IR | MCH-immunoreactive | 1 | 17 |
|
|
| IR | induce an increase of inward-rectifying | 1 | 17 |
|
|
| IR | inspiratory resistor | 1 | 17 |
|
|
| IR | 5-HT-immunoreactive | 1 | 17 |
|
|
| IR | Na+/K+-ATPase-immunoreactive | 1 | 17 |
|
|
| IR | increase of CGRP-immunoreactivity | 1 | 17 |
|
|
| IR | (5-HT)-immunoreactivity | 1 | 17 |
|
|
| IR | (ERalpha)-immunoreactivity | 1 | 16 |
|
|
| IR | CR-immunoreactive | 1 | 16 |
|
|
| IR | Inflammatory resorption | 1 | 16 |
|
|
| IR | items that varied on category | 1 | 16 |
|
|
| IR | IGF-I receptor (IGF-IR) and insulin receptor | 1 | 16 |
|
|
| IR | ischaemia reperfusion untreated | 1 | 16 |
|
|
| IR | in response to gamma-irradiation | 1 | 16 |
|
|
| IR | OA-immunoreactive | 1 | 16 |
|
|
| IR | ileo-urethrostomy with a reservoir | 1 | 16 |
|
|
| IR | Immunocytochemistry showed intensely stained NOS-immunoreactive | 1 | 16 |
|
|
| IR | (CB)-immunoreactive | 1 | 16 |
|
|
| IR | II (A II) immunoreactivity | 1 | 16 |
|
|
| IR | II insulin-requiring | 1 | 16 |
|
|
| IR | (NK1R)-immunoreactive | 1 | 16 |
|
|
| IR | NK-1r-immunoreactive | 1 | 15 |
|
|
| IR | Ir-coated catheter | 1 | 15 |
|
|
| IR | glycine-immunoreactive | 1 | 15 |
|
|
| IR | inwardly rectifying K(+) currents (I | 1 | 15 |
|
|
| IR | in met-enkephalin-immunoreactivity | 1 | 15 |
|
|
| IR | in position 23 of K | 1 | 15 |
|
|
| IR | (hcrt-1)-like-immunoreactivity | 1 | 15 |
|
|
| IR | SSD-immunoreactive | 1 | 15 |
|
|
| IR | inhibitory response | 1 | 15 |
|
|
| IR | TRH-immunoreactivity | 1 | 15 |
|
|
| IR | imidazoline receptor | 1 | 15 |
|
|
| IR | initially reactive | 1 | 14 |
|
|
| IR | FMRFamide-immunoreactive | 1 | 14 |
|
|
| IR | GAD-immunoreactivity | 1 | 14 |
|
|
| IR | inwardly rectifying K+ current | 1 | 14 |
|
|
| IR | beta-endorphin-immunoreactive | 1 | 14 |
|
|
| IR | inactivation response | 1 | 14 |
|
|
| IR | increases in QUIN immunoreactive | 1 | 14 |
|
|
| IR | NGFr-immunoreactive | 1 | 14 |
|
|
| IR | intermediate or resistant | 1 | 14 |
|
|
| IR | CB-immunoreactive | 1 | 14 |
|
|
| IR | Index of Recession | 1 | 14 |
|
|
| IR | Spectroscopic | 1 | 14 |
|
|
| IR | S100-immunoreactive | 1 | 14 |
|
|
| IR | (TH)-only-immunoreactive | 1 | 14 |
|
|
| IR | CGRP-immunoreactivity | 1 | 14 |
|
|
| IR | intestinal ischemia-reperfusion | 1 | 14 |
|
|
| IR | investigates immunoreactive | 1 | 14 |
|
|
| IR | inhibitory rates | 1 | 14 |
|
|
| IR | identical ischemia-reperfusion | 1 | 14 |
|
|
| IR | regulated by immune response | 1 | 14 |
|
|
| IR | calretinin-immunoreactive | 1 | 13 |
|
|
| IR | interchromatin region | 1 | 13 |
|
|
| IR | ischemia and 4 hours of reperfusion | 1 | 13 |
|
|
| IR | ignored repetition | 1 | 13 |
|
|
| IR | C-ACTH-immunoreactive | 1 | 13 |
|
|
| IR | initiator region | 1 | 13 |
|
|
| IR | inverted repeated sequence | 1 | 13 |
|
|
| IR | intermediate-range | 1 | 13 |
|
|
| IR | internal repeat | 1 | 13 |
|
|
| IR | ET-1-immunoreactive | 1 | 13 |
|
|
| IR | interrater agreement | 1 | 13 |
|
|
| IR | (SN)-immunoreactivity | 1 | 13 |
|
|
| IR | inwardly rectifying K(+) channels (K | 1 | 13 |
|
|
| IR | D28k-immunoreactivity | 1 | 13 |
|
|
| IR | mutant K | 1 | 13 |
|
|
| IR | cathepsin-immunoreactive | 1 | 13 |
|
|
| IR | NGFr-immunoreactivity | 1 | 13 |
|
|
| IR | in immunoreactivity | 1 | 13 |
|
|
| IR | GAT-1-immunoreactivity | 1 | 13 |
|
|
| IR | Immuno-reactive | 1 | 13 |
|
|
| IR | nNOS-immunoreactivity | 1 | 12 |
|
|
| IR | inactive trypsin-activatable renin | 1 | 12 |
|
|
| IR | iridium | 1 | 12 |
|
|
| IR | immune response genes | 1 | 12 |
|
|
| IR | (GAL)-immunoreactive | 1 | 12 |
|
|
| IR | initial virological response | 1 | 12 |
|
|
| IR | identified significant amounts of immunoreactive | 1 | 12 |
|
|
| IR | inhibition ratio | 1 | 12 |
|
|
| IR | in rat K | 1 | 12 |
|
|
| IR | infrared absorption | 1 | 12 |
|
|
| IR | 4-polyisoprene | 1 | 12 |
|
|
| IR | investigated by means of immunocytochemistry | 1 | 12 |
|
|
| IR | (GAD)-immunoreactivity | 1 | 12 |
|
|
| IR | trk-immunoreactivity | 1 | 12 |
|
|
| IR | min-ischemia-reperfusion | 1 | 12 |
|
|
| IR | immediate release capsule | 1 | 12 |
|
|
| IR | Fos-immunoreactivity | 1 | 12 |
|
|
| IR | (GnRH)-immunoreactive | 1 | 12 |
|
|
| IR | [NGFr(p75)]-immunoreactivity | 1 | 12 |
|
|
| IR | isotope renography | 1 | 12 |
|
|
| IR | irritant reaction | 1 | 12 |
|
|
| IR | (PACAP)-immunoreactive | 1 | 12 |
|
|
| IR | Y1-R-immunoreactive | 1 | 12 |
|
|
| IR | insulin levels and HOMA | 1 | 12 |
|
|
| IR | ghrelin-immunoreactive | 1 | 12 |
|
|
| IR | infrared rays | 1 | 11 |
|
|
| IR | intra-rectal | 1 | 11 |
|
|
| IR | (SOM)-immunoreactive | 1 | 11 |
|
|
| IR | interaction between gamma-aminobutyric acid (GABA)-immunoreactive | 1 | 11 |
|
|
| IR | protein)-immunoreactivity | 1 | 11 |
|
|
| IR | (bFGF)-immunoreactivity | 1 | 11 |
|
|
| IR | integration region | 1 | 11 |
|
|
| IR | VR1-immunoreactivity | 1 | 11 |
|
|
| IR | initiation region | 1 | 11 |
|
|
| IR | bFGF-immunoreactive | 1 | 11 |
|
|
| IR | infrared analysis | 1 | 11 |
|
|
| IR | immunoreactive renin | 1 | 11 |
|
|
| IR | intensity ratio | 1 | 11 |
|
|
| IR | SK3-immunoreactivity | 1 | 11 |
|
|
| IR | significantly associated with the | 1 | 11 |
|
|
| IR | Kit-immunoreactive | 1 | 11 |
|
|
| IR | NPY-immunoreactivity | 1 | 11 |
|
|
| IR | FMRFamide-like-immunoreactive | 1 | 11 |
|
|
| IR | induces tau-immunoreactivity | 1 | 11 |
|
|
| IR | (PNMT)-immunoreactive | 1 | 11 |
|
|
| IR | GluR2-immunoreactivity | 1 | 11 |
|
|
| IR | index of reactivity | 1 | 11 |
|
|
| IR | ischemia reperfusion group | 1 | 11 |
|
|
| IR | increases in plasma beta-endorphin | 1 | 11 |
|
|
| IR | ischaemia and 90 min reperfusion | 1 | 11 |
|
|
| IR | increased radio-resistence at higher doses | 1 | 11 |
|
|
| IR | GFAP-immunoreactive | 1 | 11 |
|
|
| IR | Ischemic preconditioning protects against ischemia-reperfusion | 1 | 11 |
|
|
| IR | mIgG-like-immunoreactive | 1 | 11 |
|
|
| IR | increase in immunoreactivity | 1 | 11 |
|
|
| IR | Inwardly rectifying K(+) currents (K | 1 | 11 |
|
|
| IR | infarcted region | 1 | 11 |
|
|
| IR | I receptor (IGF-IR) on ionizing radiation | 1 | 11 |
|
|
| IR | parvalbumin-immunoreactive | 1 | 11 |
|
|
| IR | intermediate | 1 | 11 |
|
|
| IR | identification in TECs/TNCs of immunoreactive | 1 | 11 |
|
|
| IR | in GR immunoreactivity | 1 | 11 |
|
|
| IR | PRV-immunoreactive | 1 | 11 |
|
|
| IR | dopamine-immunoreactive | 1 | 11 |
|
|
| IR | inventory ratio | 1 | 10 |
|
|
| IR | investigated the maturation of TK-immunoreactive | 1 | 10 |
|
|
| IR | investigated using mid-infrared spectroscopy | 1 | 10 |
|
|
| IR | inwardly rectifying K(+) currents (IK | 1 | 10 |
|
|
| IR | irrigation | 1 | 10 |
|
|
| IR | receptor-immunoreactive | 1 | 10 |
|
|
| IR | Anti-mGluR2/3-immunoreactive | 1 | 10 |
|
|
| IR | somatostatin-immunoreactive | 1 | 10 |
|
|
| IR | interstitial radiation | 1 | 10 |
|
|
| IR | interstitial radiotherapy | 1 | 10 |
|
|
| IR | ODC-immunoreactive | 1 | 10 |
|
|
| IR | interrupter technique | 1 | 10 |
|
|
| IR | (PR)-immunoreactive | 1 | 10 |
|
|
| IR | (DA)-immunoreactive | 1 | 10 |
|
|
| IR | TRH-immunoreactive | 1 | 10 |
|
|
| IR | iridium(III) bis-terpyridine complex | 1 | 10 |
|
|
| IR | I(h) and I(K | 1 | 10 |
|
|
| IR | CCK-immunoreactive | 1 | 10 |
|
|
| IR | gamma-radiation | 1 | 10 |
|
|
| IR | innervation of histamine-immunoreactive | 1 | 10 |
|
|
| IR | inferior rectus muscle | 1 | 10 |
|
|
| IR | inflammatory response | 1 | 10 |
|
|
| IR | incidence ratio | 1 | 10 |
|
|
| IR | Inhibition rates | 1 | 10 |
|
|
| IR | impregnation ratio | 1 | 10 |
|
|
| IR | in insulin-resistant | 1 | 10 |
|
|
| IR | infrared spectrophotometer | 1 | 10 |
|
|
| IR | in the appearance of ChAT-immunoreactivity | 1 | 10 |
|
|
| IR | increase in PSA-NCAM-immunoreactive | 1 | 10 |
|
|
| IR | cell surface receptor | 1 | 10 |
|
|
| IR | in response to ionizing radiation | 1 | 10 |
|
|
| IR | immediate resuscitation | 1 | 10 |
|
|
| IR | Individual GFAP immunoreactive | 1 | 10 |
|
|
| IR | insulin resistant | 1 | 10 |
|
|
| IR | Dopamine-beta-hydroxylase-immunoreactive | 1 | 9 |
|
|
| IR | nNOS-immunoreactive | 1 | 9 |
|
|
| IR | intrarenal | 1 | 9 |
|
|
| IR | (NF)-immunoreactive | 1 | 9 |
|
|
| IR | induced alterations in mAChR-immunoreactivity | 1 | 9 |
|
|
| IR | intestinal vascular endothelium after ischemia/reperfusion | 1 | 9 |
|
|
| IR | Intestinal Polypeptide)-like immunoreactivity | 1 | 9 |
|
|
| IR | irregular regeneration of hepatocytes | 1 | 9 |
|
|
| IR | 4-immunoreactivity | 1 | 9 |
|
|
| IR | double-immunoreactive | 1 | 9 |
|
|
| IR | inward rectifier (IK | 1 | 9 |
|
|
| IR | ischaemia reperfusion | 1 | 9 |
|
|
| IR | L-DOPA-immunoreactive | 1 | 9 |
|
|
| IR | (PV)-immunoreactive | 1 | 9 |
|
|
| IR | infection rate | 1 | 9 |
|
|
| IR | inertial range | 1 | 9 |
|
|
| IR | ED1-immunoreactivity | 1 | 9 |
|
|
| IR | incomplete-repair | 1 | 9 |
|
|
| IR | increases in c-Fos immunoreactivity | 1 | 9 |
|
|
| IR | NC-immunoreactive | 1 | 9 |
|
|
| IR | infrasonic recorder | 1 | 9 |
|
|
| IR | ischemia reperfusion | 1 | 9 |
|
|
| IR | TrkA-immunoreactive | 1 | 9 |
|
|
| IR | idiopathic radioculopolyneuropathies | 1 | 9 |
|
|
| IR | SOMmRNA-immunoreactivities | 1 | 9 |
|
|
| IR | increased the pituitary content of Beta-endorphin | 1 | 9 |
|
|
| IR | immunoreaction product | 1 | 9 |
|
|
| IR | synenkephalin-immunoreactivity | 1 | 9 |
|
|
| IR | insulin-stimulated processes in 32D | 1 | 9 |
|
|
| IR | internal | 1 | 9 |
|
|
| IR | intermediate risk | 1 | 9 |
|
|
| IR | immune-regulating drugs | 1 | 9 |
|
|
| IR | CGA-immunoreactive | 1 | 9 |
|
|
| IR | infra red | 1 | 9 |
|
|
| IR | infrared reflection | 1 | 9 |
|
|
| IR | immunoreactivity in the sexually dimorphic CGRP-immunoreactive | 1 | 9 |
|
|
| IR | in NIH-3T3 | 1 | 9 |
|
|
| IR | intestinal peptide (VIP)-like immunoreactive | 1 | 9 |
|
|
| IR | intestinal pathology in intestinal ischemia-reperfusion | 1 | 9 |
|
|
| IR | immunostained PKC-immunoreactive | 1 | 9 |
|
|
| IR | CR-immunoreactivity | 1 | 9 |
|
|
| IR | secretoneurin-immunoreactivity | 1 | 9 |
|
|
| IR | initiation | 1 | 9 |
|
|
| IR | X-irradiation | 1 | 8 |
|
|
| IR | irregular regeneration | 1 | 8 |
|
|
| IR | vasopressin-immunoreactive | 1 | 8 |
|
|
| IR | (ACTH)-immunoreactive | 1 | 8 |
|
|
| IR | increases Beta-endorphin | 1 | 8 |
|
|
| IR | II immunoreactivity | 1 | 8 |
|
|
| IR | immunoactive | 1 | 8 |
|
|
| IR | immediate hypersensitivity responses | 1 | 8 |
|
|
| IR | incremental running | 1 | 8 |
|
|
| IR | inadequate aspiration rate | 1 | 8 |
|
|
| IR | interobserver reproducibility | 1 | 8 |
|
|
| IR | Hsp70-immunoreactivity | 1 | 8 |
|
|
| IR | in which a constant mu | 1 | 8 |
|
|
| IR | NPFF-immunoreactive | 1 | 8 |
|
|
| IR | in Chinese hamster ovary/insulin receptor | 1 | 8 |
|
|
| IR | ischemia/reperfusion | 1 | 8 |
|
|
| IR | II (ANG II)-like immunoreactivities | 1 | 8 |
|
|
| IR | immunohistochemistry revealed close appositions between GABA-immunoreactive | 1 | 8 |
|
|
| IR | (GR)-immunoreactivity | 1 | 8 |
|
|
| IR | iron reserves | 1 | 8 |
|
|
| IR | injury following intestinal ischemia-reperfusion | 1 | 8 |
|
|
| IR | c-Met-immunoreactivity | 1 | 8 |
|
|
| IR | innervated by CARTp-immunoreactive | 1 | 8 |
|
|
| IR | Bcl-2-immunoreactivity | 1 | 8 |
|
|
| IR | infectious rhinotracheitis | 1 | 8 |
|
|
| IR | investigate the presence of immunoreactive | 1 | 8 |
|
|
| IR | intermediate region | 1 | 8 |
|
|
| IR | infrared absorption spectrometry | 1 | 8 |
|
|
| IR | Induced Reactivation | 1 | 8 |
|
|
| IR | alpha)-immunoreactive | 1 | 8 |
|
|
| IR | Indirect Radiological | 1 | 8 |
|
|
| IR | indicated that the SL-immunoreactive | 1 | 8 |
|
|
| IR | infrared radiation | 1 | 8 |
|
|
| IR | insulin stimulation of NIH-3T3 | 1 | 8 |
|
|
| IR | (NKA)-immunoreactivity | 1 | 7 |
|
|
| IR | acetyltransferase-immunoreactive | 1 | 7 |
|
|
| IR | leu-enkephalin-immunoreactive | 1 | 7 |
|
|
| IR | increase in immunoreactive | 1 | 7 |
|
|
| IR | initial increase of CGRP-immunoreactivity | 1 | 7 |
|
|
| IR | identified by immunoreactivity | 1 | 7 |
|
|
| IR | incomplete relaxation | 1 | 7 |
|
|
| IR | including ROM and isokinetic internal rotation | 1 | 7 |
|
|
| IR | I + II immunoreactivity | 1 | 7 |
|
|
| IR | interval running | 1 | 7 |
|
|
| IR | in contact with NPY-immunoreactive | 1 | 7 |
|
|
| IR | (NPF)-immunoreactivity | 1 | 7 |
|
|
| IR | intestinal peptide)-immunoreactive | 1 | 7 |
|
|
| IR | intestinal resection | 1 | 7 |
|
|
| IR | NIH-3T3 | 1 | 7 |
|
|
| IR | TH-immunoreactive | 1 | 7 |
|
|
| IR | immobility responses | 1 | 7 |
|
|
| IR | isometric relaxation | 1 | 7 |
|
|
| IR | (S1)-immunoreactivity | 1 | 7 |
|
|
| IR | Fe-restricted | 1 | 7 |
|
|
| IR | Is detected by infrared | 1 | 7 |
|
|
| IR | inwardly rectifying potassium current | 1 | 7 |
|
|
| IR | ipsilateral rotations | 1 | 7 |
|
|
| IR | IL-1beta-immunoreactivity | 1 | 7 |
|
|
| IR | increase in the density of GAD-immunoreactive | 1 | 7 |
|
|
| IR | immunocytochemistry NGF-immunoreactive | 1 | 7 |
|
|
| IR | iron removed | 1 | 7 |
|
|
| IR | isolectin B4- (IB4-) immunoreactive | 1 | 7 |
|
|
| IR | synaptophysin-immunoreactivity | 1 | 7 |
|
|
| IR | internal repeats | 1 | 7 |
|
|
| IR | sGnRH-immunoreactive | 1 | 6 |
|
|
| IR | insulin-regulatable | 1 | 6 |
|
|
| IR | intestinal polypeptide (VIP) immunoreactive | 1 | 6 |
|
|
| IR | (AADC)-immunoreactive | 1 | 6 |
|
|
| IR | SMI32-immunoreactive | 1 | 6 |
|
|
| IR | identified by synapsin-1 immunoreactivity | 1 | 6 |
|
|
| IR | interstitial ratio | 1 | 6 |
|
|
| IR | p75-immunoreactivity | 1 | 6 |
|
|
| IR | implications of p63 immunoreactivity | 1 | 6 |
|
|
| IR | interposition | 1 | 6 |
|
|
| IR | (GAD)-immunoreactive | 1 | 6 |
|
|
| IR | investigated with infrared | 1 | 6 |
|
|
| IR | increased immunoreactivity | 1 | 6 |
|
|
| IR | galanin-immunoreactive | 1 | 6 |
|
|
| IR | isocentric rotation | 1 | 6 |
|
|
| IR | irrigated rice | 1 | 6 |
|
|
| IR | NK3r-immunoreactivity | 1 | 6 |
|
|
| IR | (p75NTR)-immunoreactive | 1 | 6 |
|
|
| IR | ischemic region | 1 | 5 |
|
|
| IR | isotope ratio | 1 | 5 |
|
|
| IR | SN-immunoreactive | 1 | 5 |
|
|
| IR | isonymy | 1 | 5 |
|
|
| IR | increase in GFAP-immunoreactivity | 1 | 5 |
|
|
| IR | Met-Enk-immunoreactive | 1 | 5 |
|
|
| IR | (NT)-immunoreactive | 1 | 5 |
|
|
| IR | indicated that GABA-immunoreactive | 1 | 5 |
|
|
| IR | insulin-resistant | 1 | 5 |
|
|
| IR | intense NCS-1-immunoreactive | 1 | 5 |
|
|
| IR | intensity | 1 | 5 |
|
|
| IR | investigate the release of immunoreactive | 1 | 5 |
|
|
| IR | in the distribution of PV-immunoreactive | 1 | 5 |
|
|
| IR | in calcitonin gene-related peptide (CGRP)-immunoreactive | 1 | 5 |
|
|
| IR | immobility reflex | 1 | 5 |
|
|
| IR | Immunohistochemical analysis revealed PACAP-immunoreactivity | 1 | 5 |
|
|
| IR | insulin resistance HOMA | 1 | 4 |
|
|
| IR | (CGRP)-immunoreactivity | 1 | 4 |
|
|
| IR | isovolumic relaxation | 1 | 4 |
|
|
| IR | (VT)-immunoreactive | 1 | 4 |
|
|
| IR | I (GCH)-immunoreactive | 1 | 4 |
|
|
| IR | incidence of multiple pregnancies | 1 | 3 |
|
|
| IR | insulin resistance index | 1 | 3 |
|
|
| IR | intermediate responders | 1 | 3 |
|
|
| IR | interpersonal relations | 1 | 3 |
|
|
| IR | in EAAT1-immunoreactivity | 1 | 2 |
|
|
| IR | Visinin-immunoreactive | 1 | 2 |
|
|
| IR | Index | 1 | 2 |
|
|
| IR | oxytocin-immunoreactive | 1 | 2 |
|
|
| IR | CRH-immunoreactivity | 1 | 2 |
|
|
| IR | mGnRH-immunoreactive | 1 | 2 |
|
|
| IR | inward rectifier K(+) channels K | 1 | 2 |
|
|
| IR | inward rectification | 1 | 2 |
|
|
| IR | ET-immunoreactivity | 1 | 2 |
|
|
| IR | increase in MOR immunoreactivity | 1 | 2 |
|
|
| IR | infra-red spectroscopy | 1 | 1 |
|
|
| IR | innervation by MIP-immunoreactive | 1 | 1 |
|
|
| IR | Intraluminal irradiation | 1 | 1 |
|
|
| IR | inverted-repeat | 1 | 0 |
|
|
| IR | Islamic Republic | 1 | -1 |
|
Run A Search
Search either direction
By Acronym
By Full Name